¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"magnetic susceptibility variation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® magnetic resonance imaging(MRI) ÇÑ±Û ÀÚ±â°ø¸í¿µ»ó
¼³¸í   
  ÀÎüÀÇ Àå±â³ª, º´ÀûÀΠ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇϴ ¹æ»ç¼±ÇÐÀûÀΠ°Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í Àִ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ¼ú(CT: computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× Çػ󵵰¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é¿¡¼­ »ç¶÷À» ´ÜÃþÀ¸·Î ºÐ¸®½ÃÄÑ º¼ ¼ö Àִ µî ÀåÁ¡ÀÌ ¸¹´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í Àִ ÁßȯÀÚ µî¿¡¼­´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ºÒ¸®ÇÑ °ÍÀ¸·Î µÇ¾î ÀÖÀ¸¸ç, ¹«¾ùº¸´Ù ¼³Ä¡ºñ¿Í ±× ½Ã¼úºñ°¡ ºñ½Î´Ù´Âµ¥ °¡Àå Å« ´ÜÁ¡ÀÌ ÀÖ´Ù.
  
  
¿µ¹® nuclear magnetic resonance(NMR) ÇÑ±Û ÇÙÀÚ±â°ø¸í
¼³¸í   
  ´Ù¸¥ ¸»·Î MRI=Magnetic Resonance Imaging ÀÚ±â°ø¸í¿µ»óÀ̶ó°íµµ ÇÑ´Ù. ÀÎüÀÇ Àå±â³ª, º´ÀûÀΠ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇϴ ¹æ»ç¼±ÇÐÀûÀΠ°Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í Àִ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT=computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× Çػ󵵰¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é(plane)¿¡¼­ »ç¶÷À» ´ÜÃþ½ÃÄÑ º¼ ¼ö ÀÖ´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀÚÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í Àִ ÁßȯÀÚ µî¿¡¼­´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ¶³¾îÁö´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility
    ÀڱⰨ¼öÀ², ÀÚÈ­À², ´ëÀÚÀ²
  • magnetic susceptibility artifact
    ÀÚÈ­À²Àΰø¹°
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²±â¿ï±â
  • diurnal mood variation
    ÀÏÁß±âºÐº¯È­
  • diurnal variation
    ÇϷ纯ÀÌ, ÀÏÁߺ¯µ¿
  • ethnic variation
    ÀÎÁ¾°£º¯ÀÌ
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ
  • individual variation
    °³Ã¼º¯ÀÌ
  • interindividual variation
    °³Àΰ£º¯ÀÌ
  • phenotypic variation
    Ç¥ÇöÇüº¯ÀÌ
  • seasonal variation
    °èÀýº¯ÀÌ
  • variation
    º¯ÀÌ
  • variation curve
    º¯À̰
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • static magnetic field
    Á¤ÀÚ±âÀå
  • magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í
  • susceptibility
    °¨¼ö¼º
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
  • variation
    º¯ÀÌ
  • concomitant variation
    µ¿½Ãº¯ÀÌ
  • diurnal variation
    ÇϷ纯ÀÌ
  • ethnic variation
    ÀÎÁ¾°£º¯ÀÌ
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ
  • individual variation
    °³Ã¼º¯ÀÌ
  • interindividual variation
    °³Àΰ£º¯ÀÌ
  • observer variation
    °üÂûÀÚº¯ÀÌ
  • phenotypic variation
    Ç¥ÇöÇüº¯ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility artifact
    ÀÚ±âÈ­À²Àΰø¹°
  • magnetic susceptibility proton relaxation enhancement
    ÀÚ±âÈ­À²¾ç¼ºÀÚÀÌ¿ÏÁõ°­
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²±â¿ï±â
  • magnetic susceptibility
    ÀÚ±âÈ­À²
  • volume magnetic susceptibility
    ¿ëÀûÀÚ±âÈ­À²
  • variation curve
    º¯À̰
  • diurnal variation
    ÇϷ纯ÀÌ
  • dose rate variation
    ¼±·®·üº¯ÀÌ
  • ethnic variation
    ÀÎÁ¾°£º¯ÀÌ
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ
  • individual variation
    °³Ã¼º¯ÀÌ
  • induced variation
    À¯µµº¯ÀÌ
  • interindividual variation
    °³Àΰ£º¯ÀÌ
  • intrapair variation
    ½ÖµÕÀ̰£º¯ÀÌ
  • observer variation
    °üÂûÀÚº¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MRI = Magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó(í¸Ñ¨ÍìÙ°ç±ßÀ)
  • Magnetic resonance imaging = MRI
    ÀÚ±â°ø¸í¿µ»ó(í¸Ñ¨ÍìÙ°ç±ßÀ)(í¸Ñ¨ÍöÙ¢ç±ßÀ)
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • functional magnetic resonance imaging (fMRI)
    ±â´ÉÀû ÀÚ±â°ø¸í¿µ»ó
  • gradient magnetic coil
    °æ»ç ÀÚ±â ÄÚÀÏ
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • antifungal susceptibility testing
    Ç×Áø±Õ°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility testing
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè¹ý
  • genetic susceptibility
    À¯ÀüÀû °¨¼ö¼º
  • genetic susceptibility
    À¯ÀüÀÚ°¨¼ö¼º
  • S-R variation
    S-Rº¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility variation
    ÀÚ±âÈ­À² º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gradient echo technique magnetic susceptibility pro
    °æ»ç ¿¡ÄÚ¹ý ÀÚ±âÈ­À² ¾ç¼ºÀÚ ÀÌ¿Ï Áõ°­
  • magnetic susceptibility
    ÀÚ±âÈ­À²
  • magnetic susceptibility artefact
    ÀÚ±âÈ­À² Àΰø¹°
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À² °æ»ç
  • volume magnetic susceptibility
    ¿ëÀû ÀÚÈ­À²
  • antifungal susceptibility testing
    Ç×Áø±Õ°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility testing
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè¹ý
  • atomic susceptibility
    ¿øÀÚÀÚÈ­À² (¡­í¸ûùëÒ).
  • colo(u)rimetric caries susceptibility test
    ¿ì½Ä°¨¼ö¼º ºñ»ö½ÃÇè(ó»ãÝÊïáô àõÝïßäãËúÐ).
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • disk dilution susceptibility test
    µð½ºÅ©Èñ¼®°¨¼ö¼º½ÃÇè
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Variation
    º¯ÀÌ
    [¿¾ ¿ë¾î] º¯ÀÌ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • host susceptibility
    ¼÷ÁÖ°¨¼ö¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility
    ÀÚÈ­À²(í¸ûùëÒ)
  • coefficient of variation
    ºÐ»ê°è¼ö(ÝÂߤÌõâ¦)
  • continuous variation
    ¿¬¼Óº¯ÀÌ(ææáÙܨì¶)
  • genotypic variation
    À¯ÀüÀÚÇü º¯µ¿(ë¶îîí­úþܨÔÑ)
  • method of continuous variation
    ¿¬¼Óº¯È­¹ý(Ö§áÙܨûùÛö)
  • phase variation
    »óº¯µ¿(ßÓܨÔÑ)
  • phenotypic variation
    Ç¥ÇöÇü º¯µ¿(øúúÞúþܨÔÑ)
  • rough-smooth variation
    Á¶È°(ðØüÁ) º¯ÀÌ(ܨì¶)
  • smooth-rough variation
    ȰÁ¶ º¯ÀÌÁÖ(üÁðØÜ¨ì¶ñ»)
  • S -> R variation
    S ¡æR º¯µ¿(ܨÔÑ)
  • electron magnetic resonance
    ÀüÀÚ ÀÚ±â°ø¸í(ï³í­í¸Ñ¨ÍìÙ°)
  • Fourier transform nuclear magnetic resonance
    Ǫ¸®¿¡ º¯È¯(ܨüµ) ÇÙÀÚ±â°ø¸í(ú·í¸Ñ¨ÍìÙ°)
  • magnetic affinity chromatography
    ÀÚ±âģȭ(í¸ÐïöÑûú) Å©·Î¸¶Åä±×·¡ÇÇ
  • magnetic circular dichroism
    Àڱ⠿øÆí±¤ÀÌ»ö¼º(í¸Ðïê­ø¶ÎÃì£ßäàõ)
  • magnetic dipole
    ÀÚ±â½Ö±ØÀÚ(í¸ÐïäªÐ¿í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility variation
    ÀÚ±âÈ­À²º¯ÀÌ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • magnetic susceptibility
    ÀÚ±âÈ­À²
  • magnetic susceptibility artefact
    ÀÚ±âÈ­À²Àΰø¹°
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²°æ»ç
  • volume magnetic susceptibility
    ¿ëÀûÀÚÈ­À²
  • interobserver variation
    °üÂûÀÚ°£º¯ÀÌ
  • variation
    º¯ÀÌ, º¯µ¿
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • mass susceptibility
    Áú·®¹Î°¨µµ
  • molar susceptibility
    ¸ô´ç·®°¨¼ö¼º
  • paramagnetic high susceptibility
    »óÀÚ¼º°íÀÚÈ­À²
  • paramagnetic susceptibility effect
    »óÀÚ¼ºÀÚ±âÈ­È¿°ú
  • susceptibility
    °¨¼ö¼º, ÀÌȯ¼º, ÀÚÈ­À²
  • susceptibility artifact
    ÀÚÈ­À²Àΰø¹°, °¨¼ö¼ºÀΰøÀ½¿µ
  • susceptibility distortions
    ÀÚÈ­À²¿Ö°î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
B1 induced field in magnetic resonance imaging; radiofrequency magnetic field in nuclear magnetic reson...
MSS Marshall-Smith syndrome; massage; Medical Superintendents' Society; Medicare Statistical System; men...
cm magnetic susceptibility
B0 constant magnetic field in nuclear magnetic resonance
Bo constant magnetic field in a magnetic resonance scanner
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DSC Dynamic susceptibility contrast
HGSHS:A Harvard Group Scale of Hypnotic Susceptibility, Form A
MHS Malignant hyperthermia susceptibility
S R)/susceptibility
SHSS:C Standford Hypnotic Susceptibility Scale, Form C
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • magnetic susceptibility variation
    ÀÚ±âÈ­À² º¯ÀÌ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • magnetic susceptibility artifact
    ÀÚ±âÈ­À² Àΰø¹°
  • antimicrobial susceptibility
    Ç×±ÕÁ¦ °¨¼ö¼º, Ç×±Õ °¨¼ö¼º
  • caries susceptibility test
    Ä¡¾Æ ¿ì½Ä °¨¼ö¼º ½ÃÇè
  • mass susceptibility
    Áú·® ¹Î°¨µµ
  • paramagnetic high susceptibility
    »óÀÚ¼º °íÀÚÈ­À²
  • paramagnetic susceptibility effect
    »óÀÚ¼º ÀÚ±âÈ­ È¿°ú
  • susceptibility test
    °¨¼ö¼º ½ÃÇè, °¨¼ö¼º Å×½ºÆ®, °¨¼ö¼º °Ë»ç
  • bacterial variation
    ¼¼±Õ º¯ÀÌ
    ¼¼±ÕÀÌ µ¿Á¤°ú ºÐÈ­¸¦ ÇÏ´Â µ¥ ¾²À̴ Ư¡ÀÇ ¹üÀ§.
  • caliber variation
    ±¸°æ º¯·®
  • carcadian variation
    ?
  • diurnal variation
    ÁÖ°£ º¯µ¿, ÀÏÁÖ º¯È­
  • dose rate variation
    ¼±·®·ü º¯È­
  • interobserver variation
    °üÂûÀÚ°£ º¯ÀÌ
  • monophasic variation
    ´Ü»ó¼º º¯È­
  • severe variation
    ½ÉÇÑ º¯Çü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antigenic variation The phenomenon of changes in surface antigens in parasitic populations of Trypanosoma and Plasmodium (and some other parasitic protozoa) in order to escape immunological defense mechanisms. at least 100 different surface proteins have been found to appear and disappear during antigenic variation in a clone of trypanosomes. Each antigen is encoded in a separate gene. Antigenic variation is also known to occur in free living Protozoa and certain bacteria.
(18 Nov 1997)
BRCA1 breast cancer susceptibility gene This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer.
(12 Dec 1998)
breast cancer susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
cancer, breast, susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
cancer susceptibility gene tumour suppressor gene
variation In genetics, deviation in characters in an individual from those typical of the group to which it belongs, also, deviation in characters of the offspring from those of its parents.
(18 Nov 1997)
variation (genetics) The phenotypic differences among individuals in a population.
(12 Dec 1998)
genes, breast cancer susceptibility Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. Howeverm, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. See related entries to: BRCA1; BRCA2; Breast cancer, familial.
(12 Dec 1998)
phase variation <microbiology> Alteration in the expression of surface antigens by bacteria.
For example: Salmonella can express either of two forms of flagellin, H1 and H2, that are coded by different genes. Control of which form is expressed is brought about by inversion of the promoter for the H2 gene, which if functional (noninverted) is associated with the expression of H2 and the production of a repressor of the H1 gene.
Inversion occurs about every 1000 bacterial divisions and is under the control of another gene, hin, that is within the invertable sequence.
(31 Dec 1997)
coefficient of variation The ratio of the standard deviation to the mean.
(05 Mar 2000)
colourimetric caries susceptibility test A colourimetric test for determining dental caries activity or susceptibility based on the rate of acid production by acidogenic oral microorganisms (e.g., lactobacillus) in a glucose medium, using bromcresol green as the indicator, and producing a colour change from green to yellow.
Synonym: colourimetric caries susceptibility test.
(05 Mar 2000)
contingent negative variation An increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus. It is an electrical event indicative of a state of readiness or expectancy.
(12 Dec 1998)
somaclonal variation The variation between individuals in a clone, particularly in plant clones. While the objective is usually to grow clones without variation, somaclonal variation does provide the opportunity to generate new plant types that would be harder or impossible to generate by conventional plant breeding.
(14 Nov 1997)
susceptibility Origin: Cf. F. Susceptibilite.
1. The state or quality of being susceptible; the capability of receiving impressions, or of being affected.
2. Specifically, capacity for deep feeling or emotional excitement; sensibility, in its broadest acceptation; impressibility; sensitiveness.
<physics> Magnetic susceptibility, the intensity of magnetization of a body placed in a uniform megnetic field of unit strength.
Synonym: Capability, sensibility, feeling, emotion.
Source: Websters Dictionary
(01 Mar 1998)
susceptibility testing The determination of the ability of an antibiotic to kill or inhibit the growth of bacteria.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • susceptibility
    °¨¼ö¼º
  • susceptibility
    °¨¼ö¼º(to);°¨Á¤
  • variation
    º¯È­
  • grid variation
    ±×¸®µå ÆíÂ÷(ÁøÁ¤ ÀÚ¿À¼±°ú ÀÚ±â ÀÚ¿À¼±ÀÇ ±³°¢)
  • variation
    º¯È­;º¯µ¿;º¯È­·®(Á¤µµ);º¯È­¹°;º¯ÁÖ°î;º¯ÀÌ
  • magnetic
    ÀÚ±â
  • magnetic
    Àڱ⼺ÀÌ ÀÖ´Â;¸Å·Â ÀÖ´Â
  • magnetic (dipole) moment
    Àڱ⠽ְîÀÚ ¸ð¸àÆ®;Àڱ⠸ð¸àÆ®
  • magnetic bubble
    Æ÷ÀÚ±¸(ÀÚ¼ºÀç ¾È¿¡ ³ªÅ¸³ª´Â ¿øÁÖ²ÃÀÇ ÀÚ±¸)
  • magnetic card
    ÀÚ±â Ä«µå
  • magnetic circuit
    ÀÚ±â ȸ·Î
  • magnetic compass
    ÀÚ±â ÄÄÆÛ½º(³ªÄ§ÀÇ)
  • magnetic core
    (ÄÄÇ»ÅÍ) ÀÚ±â ÄÚ¾î(±â¾ï ¼ÒÀÚ·Î ¾²ÀÌ´Â ÀÚöÀÇ ÀÛÀº °í¸®)
  • magnetic declination
    ÀÚ±â Æí°¢
  • magnetic detector
    ÀÚ±â °ËÆÄ±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á